Effects of COVID-19 Mental Health Interventions Among Children, Adolescents, and Adults Not Quarantined or Undergoing Treatment Due to COVID-19 Infection: A Systematic Review of Randomised Controlled Trials.


Journal

Canadian journal of psychiatry. Revue canadienne de psychiatrie
ISSN: 1497-0015
Titre abrégé: Can J Psychiatry
Pays: United States
ID NLM: 7904187

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 12 3 2022
medline: 4 5 2022
entrez: 11 3 2022
Statut: ppublish

Résumé

Our objective was to assess the effects of mental health interventions for children, adolescents, and adults not quarantined or undergoing treatment due to COVID-19 infection. We searched 9 databases (2 Chinese-language) from December 31, 2019, to March 22, 2021. We included randomised controlled trials of interventions to address COVID-19 mental health challenges among people not hospitalised or quarantined due to COVID-19 infection. We synthesized results descriptively due to substantial heterogeneity of populations and interventions and risk of bias concerns. We identified 9 eligible trials, including 3 well-conducted, well-reported trials that tested interventions designed specifically for COVID-19 mental health challenges, plus 6 other trials with high risk of bias and reporting concerns, all of which tested standard interventions (e.g., individual or group therapy, expressive writing, mindfulness recordings) minimally adapted or not specifically adapted for COVID-19. Among the 3 well-conducted and reported trials, 1 ( Interventions that adapt evidence-based strategies for feasible delivery may be effective to address mental health in COVID-19. More well-conducted trials, including for children and adolescents, are needed.

Identifiants

pubmed: 35275494
doi: 10.1177/07067437211070648
pmc: PMC9065490
doi:

Types de publication

Journal Article Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-350

Subventions

Organisme : CIHR
ID : CMS-171703
Pays : Canada
Organisme : CIHR
ID : MS1-173070
Pays : Canada

Références

Telemed J E Health. 2021 Jun;27(6):594-602
pubmed: 32970532
BMJ. 2001 Jul 7;323(7303):42-6
pubmed: 11440947
JMIR Ment Health. 2021 Mar 2;8(3):e26550
pubmed: 33650985
BMJ. 2020 May 12;369:m1847
pubmed: 32398241
Front Psychol. 2021 Feb 22;12:577187
pubmed: 33692715
Front Psychol. 2020 Nov 10;11:587282
pubmed: 33240180
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
JMIR Ment Health. 2021 Feb 12;8(2):e26683
pubmed: 33512323
Healthc Manage Forum. 2020 Nov;33(6):282-287
pubmed: 32613867
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
JAMA Psychiatry. 2021 Jun 1;78(6):616-622
pubmed: 33620417
N Engl J Med. 2008 Jan 17;358(3):252-60
pubmed: 18199864
Int J Environ Res Public Health. 2021 Feb 28;18(5):
pubmed: 33670974
Braz J Psychiatry. 2021 Nov-Dec;43(6):665-678
pubmed: 33852690
Psychother Psychosom. 2021;90(3):191-199
pubmed: 33212440
Psychol Med. 2019 Jun;49(8):1266-1274
pubmed: 30688184
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Int J Environ Res Public Health. 2021 Jan 19;18(2):
pubmed: 33477831
Lancet Rheumatol. 2021 Jun;3(6):e427-e437
pubmed: 33899008
JAMA Psychiatry. 2017 Apr 01;74(4):351-359
pubmed: 28241179
J Psychosom Res. 2020 Jun;133:110113
pubmed: 32354463
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
Psychiatry Res. 2020 Nov;293:113441
pubmed: 32898840
JAMA. 2018 Dec 25;320(24):2529-2530
pubmed: 30500053
J Clin Epidemiol. 2015 Nov;68(11):1312-24
pubmed: 25721570
Gen Hosp Psychiatry. 2020 Sep - Oct;66:133-146
pubmed: 32858431
Front Psychol. 2020 Oct 28;11:563876
pubmed: 33192837
J Clin Epidemiol. 2017 Nov;91:23-30
pubmed: 28912002

Auteurs

Olivia Bonardi (O)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Yutong Wang (Y)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Kexin Li (K)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Xiaowen Jiang (X)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Ankur Krishnan (A)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Chen He (C)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Ying Sun (Y)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Yin Wu (Y)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.

Jill T Boruff (JT)

Schulich Library of Physical Sciences, Life Sciences, and Engineering, 5620McGill University, Montreal, Quebec, Canada.

Sarah Markham (S)

Department of Biostatistics and Health Informatics, King's College London, London, United Kingdom.

Danielle B Rice (DB)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychology, 5620McGill University, Montreal, Quebec, Canada.

Ian Thombs-Vite (I)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Amina Tasleem (A)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychology, 5620McGill University, Montreal, Quebec, Canada.

Tiffany Dal Santo (TD)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychology, 5620McGill University, Montreal, Quebec, Canada.

Anneke Yao (A)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychology, 5620McGill University, Montreal, Quebec, Canada.

Marleine Azar (M)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Branka Agic (B)

7978Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, 7938University of Toronto, Toronto, Ontario, Canada.

Christine Fahim (C)

Li Ka Shing Knowledge Institute, Unity Health Toronto, Toronto, Ontario, Canada.

Michael S Martin (MS)

School of Epidemiology and Public Health, University of Ottawa, Ontario, Canada.
Correctional Service of Canada, Ottawa, Ontario, Canada.

Sanjeev Sockalingam (S)

7978Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
149914Department of Psychiatry, 7938University of Toronto, Toronto, Ontario, Canada.

Gustavo Turecki (G)

Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
McGill Group for Suicide Studies, Douglas Mental Health University Institute, 5620McGill University, Montreal, Quebec, Canada.

Andrea Benedetti (A)

Department of Epidemiology, Biostatistics, and Occupational Health, 5620McGill University, Montreal, Quebec, Canada.
Department of Medicine, 5620McGill University, Montreal, Quebec, Canada.
Respiratory Epidemiology and Clinical Research Unit, 5620McGill University Health Centre, Montreal, Quebec, Canada.

Brett D Thombs (BD)

113635Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychiatry, 5620McGill University, Montreal, Quebec, Canada.
Department of Psychology, 5620McGill University, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, 5620McGill University, Montreal, Quebec, Canada.
Department of Medicine, 5620McGill University, Montreal, Quebec, Canada.
Department of Educational and Counselling Psychology, 5620McGill University, Montreal, Quebec, Canada.
Biomedical Ethics Unit, 5620McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH